Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and Stem Cell Transplant for Relapsed Childhood ALCL
NCT00317408Phase 2Unknown
- Start
- Apr 2004
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 2, open-label trial of vinblastine in anaplastic large cell lymphoma (ALCL) (4 arms). Primary endpoint: Event-Free Survival. Status: unknown.
02
Drugs
vinblastine
03
Conditions
anaplastic large cell lymphoma (ALCL)
Beyond the preview
Go deeper on NCT00317408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317408.